The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma HemoglobinRussell P. Rother, Mark T. Gladwin, Leonard Bell et al.|JAMA|2005Cited by 1.5k
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell diseaseGregory J. Kato, Mark T. Gladwin|Blood|2005Cited by 643
Nitric Oxide Scavenging by Red Blood Cell Microparticles and Cell-Free Hemoglobin as a Mechanism for the Red Cell Storage LesionChenell Donadee, Mark T. Gladwin|Circulation|2011Cited by 561
Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsGregory J. Kato, Mark T. Gladwin|American Journal of Hematology|2009Cited by 343
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell DiseaseElizabeth S. Klings, Mark T. Gladwin, Roberto F. Machado et al.|American Journal of Respiratory and Critical Care Medicine|2014Cited by 256